Clinical Trials on Experiential Avoidance in Mexico
Total 1 results
-
University of New MexicoRecruitingAnorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa | Avoidant/Restrictive Food Intake DisorderUnited States
Sponsors and Collaborators
- California Foundation for Occupational Therapy
- Benizelion General Hospital
- Muusmann forlag
- Avacta Life Sciences Ltd
- Dr. Jose María Martos Becerra (Central Radiological Assessment) - Hospital de Alta Resolución, Puente Genil (Spain)
- Ambiotis (Toulouse, France)
- Dayton Children's - Northwest Campus
- Sharma, Kumar, M.D.
- International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine
- Allievex Corporation
- Xuzhou maternal and Child Health Care Hospital
- Scientific Advisory Board for Defence (MATINE)
- Hanita Lenses
- Medtronic, Inc., a Minnesota, U.S.A. company
- Ada Health GmbH
- Sonosemi Medical Co., Ltd.
- Zhiqing, Liang
- Banco Nacional de Desenvolvimento Economico e Social
- Admiraal de Ruyter Hospital
- D.E.L., LLC
- View Full List
Medical Conditions
- Immune Reconstitution Syndrome
- Personal Health Information
- Immune Function and Intestinal Microbiota
- Functional Disabilities
- Prolactin Secreting Adenoma
- Surgical Complication Nec
- Non Hodgkin's Lymphoma
- Mild-to-moderate COVID-19
- Ionized Calcium
- Nonvariceal Upper Gastrointestinal Bleeding
- Dendritic Cells
- Perimembranous Ventricular Septal Defect
- Acceptance of Immediate ART
- Metabolic Bone Disorder
- Class II Caries in Posterior Teeth
- Carotid Intimal Medial Thickness 1
- Antiviral Toxicity
- Diffuse Gastric Cancer
- This is the Contact Registry
- Career Burnout
- View Full List
Drug Interventions
- Mylan's insulin glargine
- MRNA
- G-CSF
- Durvalumab
- Compressed tablet of safoof e muhazzil
- Ziprasidone
- Iron sucrose, erythropoietin-β
- Oxaliplatin injection
- TQC3564 tablets
- Omalizumab 150mg
- Cannabidiol (CBD)
- Mutaflor® Suspension
- LCZ696
- AS703569
- Nab-paclitaxel
- Cixutumumab
- Sorafenib
- Rotator interval hydro-dissection with corticosteroid solution
- ABL301
- Ivermectin Lotion, 0.5%
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kenya
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Senegal
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Uganda
- CRO list by country